Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Industry Conferences in October NEW.
04.10.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in . Seite 1
EQS-News: ABIVAX / Key word(s): MiscellaneousABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022 27.09.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax abstract on obefazimod phase 2b results selected for moderate.
Abivax abstract on obefazimod phase 2b results selected for moderated poster presentation at UEG Week 2022Obefazimod (ABX464) interim 48-week safety and efficacy analysis from the ongoing phase 2b maintenance